Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for fatigue in breast cancer radiation
NCT02137252Phase 2Terminated
- Sponsor
- Dana-Farber Cancer Institute
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in fatigue, sponsored by Dana-Farber Cancer Institute. Started May 2014; status: terminated.
02
Drugs
naltrexone
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT02137252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137252.